Middle East & Africa Clinical Nutrition Market: By Product Type (Premixed, Vitamins & Minerals, Carbohydrates, and Amino Acids), By Therapeutic Area (Critical Care, Cancer, GI Tract Impairment, Malnutrition & Metabolic Disorders, Allergy & Inflammation, and Others), By Route of Administration (Oral Nutrition, Enteral Nutrition, and Parenteral Nutrition), By End User (Hospitals/Clinics and Homecare), and By Country (Saudi Arabia, UAE, Iran, Iraq, Jordan, Qatar, Oman, Bahrain, South Africa, Egypt, and Morocco) - Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 104 pages | ID: MB40556EC78EN
Precision Business Insights (PBI)

Abstracts

Middle East & Africa Clinical Nutrition Market Report Description:

Middle East & Africa clinical nutrition market report gives comprehensive outlook on clinical nutrition products adoption pattern across the region with special emphasis on key countries such as Saudi Arabia, UAE, Iran, Iraq, Jordan, Qatar, Oman, Bahrain, South Africa, Egypt, Morocco, and Rest of Middle East & Africa. The report on Middle East & Africa clinical nutrition market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, therapeutic area, route of administration, end user and country. This report presents Middle East & Africa clinical nutrition market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the Middle East & Africa clinical nutrition market. In addition, Middle East & Africa clinical nutrition market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Middle East & Africa clinical nutrition market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Middle East & Africa clinical nutrition market report include raw material suppliers, manufacturers, marketers, policy makers, and healthcare service providers, who are engaged in usage and advocacy of clinical nutrition products.

Middle East & Africa Clinical Nutrition Market:

Middle East & Africa clinical nutrition market was valued around US$ 360 Mn in 2016 and poised to grow around 3.5% CAGR over 2017-2023.

COMPETITION ASSESSMENT

Key players profiles in the Middle East & Africa Clinical Nutrition market include:

• Ajinomoto Co. Inc.
• Perrigo Company Plc.
• Abbott Nutrition Inc.
• Baxter International Inc.
• Danon Baby and Medical Nutrition BV
• B. Braun Medical Inc.
• Fresenius Kabi AG
• Hospira (Pfizer) Inc.
• Gentiva Health Services Inc.
• Hero Nutritional Inc.
• Nestle SA.

Players in the Middle East & Africa Clinical Nutrition market are entering into partnerships and collaborations, launching products in the market to garner larger market share

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED SEGMENTATION

By Product Type

• Premixed
• Vitamins & Minerals
• Carbohydrates
• Amino Acids

By Therapeutic Area

• Critical Care
• Cancer
• GI Tract Impairment
• Malnutrition & Metabolic Disorders
• Allergy & Inflammation
• Others

By Route of Administration

• Oral Nutrition
• Enteral Nutrition
• Parenteral Nutrition

By Country

• Saudi Arabia
• UAE
• Iran
• Iraq
• Jordan
• Qatar
• Oman
• Bahrain
• South Africa
• Egypt
• Morocco
• Rest of Middle East & Africa

Contents

1. EXECUTIVE SUMMARY

2. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET INTRODUCTION

2.1. Middle East & Africa Clinical Nutrition Market – Taxonomy
2.2. Middle East & Africa Clinical Nutrition Market –Definitions
  2.2.1. Product Type
  2.2.2. Route of Administration
  2.2.3. Therapeutic Area

3. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Middle East & Africa Clinical Nutrition Market Dynamics – Factors Impact Analysis
3.6. Middle East & Africa Clinical Nutrition Market – Regulations
  3.6.1. Saudi Arabia
  3.6.2. UAE
  3.6.3. Iran
  3.6.4. Iraq
  3.6.5. Jordan
  3.6.6. Qatar
  3.6.7. Oman
  3.6.8. Bahrain
  3.6.9. South Africa
  3.6.10. Egypt
  3.6.11. Morocco
3.7. Middle East & Africa Clinical Nutrition Market – Product Innovations

4. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Premixed
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.1.3. Market Opportunity Analysis
5.2. Vitamins & Minerals
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.2.3. Market Opportunity Analysis
5.3. Carbohydrates
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.3.3. Market Opportunity Analysis
5.4. Amino Acids
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.4.3. Market Opportunity Analysis

6. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET FORECAST, THERAPEUTIC AREA, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Critical Care
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Cancer
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. GI Tract Impairment
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. Malnutrition & Metabolic Disorders
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis
6.5. Allergy & Inflammation
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.5.3. Market Opportunity Analysis
6.6. Others
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.6.3. Market Opportunity Analysis

7. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Oral Nutrition
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Enteral Nutrition
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Parenteral Nutrition
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis

8. MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET FORECAST, BY COUNTRY, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Saudi Arabia
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. UAE
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. Iran
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Iraq
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis
8.5. Jordan
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.5.3. Market Opportunity Analysis
8.6. Qatar
  8.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.6.3. Market Opportunity Analysis
8.7. Oman
  8.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.7.3. Market Opportunity Analysis
8.8. South Africa
  8.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.8.3. Market Opportunity Analysis
8.9. Egypt
  8.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.9.3. Market Opportunity Analysis
8.10. Morocco
  8.10.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.10.3. Market Opportunity Analysis
8.11. Rest of Middle East & Africa
  8.11.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.11.3. Market Opportunity Analysis
8.12. Middle East & Africa Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, Route of Administration, and Region, 2017 – 2023

9. SAUDI ARABIA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    9.1.1.1. Premixed
    9.1.1.2. Vitamins & Minerals
    9.1.1.3. Carbohydrates
    9.1.1.4. Amino Acids
  9.1.2. Therapeutic Area Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Premixed
    9.1.2.2. Vitamins & Minerals
    9.1.2.3. Carbohydrates
    9.1.2.4. Amino Acids
  9.1.3. Route of Administration Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Premixed
    9.1.3.2. Vitamins & Minerals
    9.1.3.3. Carbohydrates
    9.1.3.4. Amino Acids
  9.1.4. Saudi Arabia Product Testing Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, Route of Administration, and Country, 2017 – 2023
  9.1.5. Saudi Arabia Product Testing Market Dynamics – Trends

10. UAE CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

11. IRAN CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

12. IRAQ CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

13. JORDAN CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

14. QATAR CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

15. OMAN CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

16. BAHRAIN CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

17. SOUTH AFRICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

18. EGYPT CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

19. MOROCCO CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

20. REST OF MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

21. COMPETITION LANDSCAPE

21.1. Strategic Dashboard of Top Market Players
21.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  21.2.1. Ajinomoto Co. Inc.
  21.2.2. Perrigo Company Plc.
  21.2.3. Abbott Nutrition Inc.
  21.2.4. Baxter International Inc.
  21.2.5. Danon Baby and Medical Nutrition BV
  21.2.6. B. Braun Medical Inc.
  21.2.7. Fresenius Kabi AG
  21.2.8. Hospira (Pfizer) Inc.
  21.2.9. Gentiva Health Services Inc.
  21.2.10. Hero Nutritional Inc.
  21.2.11. Nestle SA.

22. RESEARCH METHODOLOGY

23. KEY ASSUMPTIONS AND ACRONYMS